Literature DB >> 15702328

Diffuse choroidal haemangioma in Sturge-Weber syndrome treated with photodynamic therapy under general anaesthesia.

E A Huiskamp1, R P H M Müskens, A Ballast, J M M Hooymans.   

Abstract

PURPOSE: To report the treatment outcome of photodynamic therapy with verteporfin (PDT) for exudative retinal detachment associated with diffuse choroidal haemangioma in Sturge-Weber syndrome.
METHODS: An interventional case report of a 12-year-old girl with Sturge-Weber syndrome who developed an exudative retinal detachment (visual acuity 20/400) that was treated with PDT under general anaesthesia. PDT was performed according to the standard (macular degeneration) protocol, using three nonoverlapping spots of 4,000 microm.
RESULTS: Subretinal fluid resolved completely over a period of 5 months and visual acuity increased to 20/50. No side effects of the PDT treatment were encountered during 9 months' follow-up.
CONCLUSION: In our patient PDT with verteporfin effectively resolved the exudative retinal detachment associated with a diffuse choroidal haemangioma. Resolution of subretinal fluid occurred over several months without retreatment. We noted no side effects of the combination PDT and general anaesthesia, nor did we encounter ocular side effects of the treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15702328     DOI: 10.1007/s00417-004-1102-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  10 in total

1.  Photodynamic therapy using verteporfin for a diffuse choroidal hemangioma in Sturge-Weber syndrome.

Authors:  Harshivinderjit S Bains; Anthony C Cirino; Benjamin H Ticho; Lee M Jampol
Journal:  Retina       Date:  2004-02       Impact factor: 4.256

2.  Circumscribed choroidal hemangiomas.

Authors:  R Anand; J J Augsburger; J A Shields
Journal:  Arch Ophthalmol       Date:  1989-09

3.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1999-10

4.  Risk factors for radiation maculopathy and papillopathy after intraocular irradiation.

Authors:  E S Gragoudas; W Li; A M Lane; J Munzenrider; K M Egan
Journal:  Ophthalmology       Date:  1999-08       Impact factor: 12.079

5.  Transpupillary thermotherapy (TTT) in circumscribed choroidal hemangioma.

Authors:  Anne V Fuchs; Arthur J Mueller; Martin Grueterich; Michael W Ulbig
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2001-11-22       Impact factor: 3.117

6.  Severe pigment epithelial alterations in the treatment area following photodynamic therapy for classic choroidal neovascularization in young females.

Authors:  Laurence Postelmans; Brigitte Pasteels; Pascale Coquelet; Hind El Ouardighi; Claire Verougstraete; Ursula Schmidt-Erfurth
Journal:  Am J Ophthalmol       Date:  2004-11       Impact factor: 5.258

7.  Transpupillary thermotherapy for circumscribed choroidal hemangiomas.

Authors:  J García-Arumí; L S Ramsay; B C Guraya
Journal:  Ophthalmology       Date:  2000-02       Impact factor: 12.079

8.  Photodynamic therapy for diffuse choroidal hemangioma associated with Sturge Weber syndrome.

Authors:  Rajiv Anand
Journal:  Am J Ophthalmol       Date:  2003-10       Impact factor: 5.258

9.  Proton beam irradiation of choroidal hemangiomas.

Authors:  L Zografos; E Egger; L Bercher; L Chamot; G Munkel
Journal:  Am J Ophthalmol       Date:  1998-08       Impact factor: 5.258

10.  Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome.

Authors:  Michel E Farah; Rogério A Costa; Cristina Muccioli; Tércio A Guia; Rubens Belfort
Journal:  Am J Ophthalmol       Date:  2002-07       Impact factor: 5.258

  10 in total
  5 in total

1.  Focal venous hypertension as a pathophysiologic mechanism for tissue hypertrophy, port-wine stains, the Sturge-Weber syndrome, and related disorders: proof of concept with novel hypothesis for underlying etiological cause (an American Ophthalmological Society thesis).

Authors:  Cameron F Parsa
Journal:  Trans Am Ophthalmol Soc       Date:  2013-09

Review 2.  Verteporfin PDT for non-standard indications--a review of current literature.

Authors:  Wai Man Chan; Tock-Han Lim; Alfredo Pece; Rufino Silva; Nagahisa Yoshimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-02-17       Impact factor: 3.117

3.  Progressive retinal vessel malformation in a premature infant with Sturge-Weber syndrome: a case report and a literature review of ocular manifestations in Sturge-Weber syndrome.

Authors:  Zhengping Hu; Jian Cao; Eun Young Choi; Yun Li
Journal:  BMC Ophthalmol       Date:  2021-01-22       Impact factor: 2.209

4.  Sympathetic Ophthalmia in a 22-Month-Old Infant With Sturge-Weber Syndrome With Atypical Histopathological Correlation.

Authors:  Linda A Cernichiaro-Espinosa; Aaron S Gold; Audina M Berrocal; Sander R Dubovy; Ta Chen Chang; Abby Orcutt-Hayes; Timothy G Murray
Journal:  J Vitreoretin Dis       Date:  2018-06-20

5.  Transient increased exudation after photodynamic therapy of intraocular tumors.

Authors:  Arman Mashayekhi; Carol L Shields; Jerry A Shields
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.